Prognostic parameters for survival of patients with malignant mesenchymal tumors of the uterus

Malignant mesenchymal uterine neoplasms are the most aggressive type of primary uterine tumors, with most patients dying within a few years of diagnosis. Thus, it would be very important to define prognostic factors for predicting the malignancy potential of at least some of their subtypes.

[1]  E. Yordan,et al.  Prognostic factors in early‐stage uterine sarcoma: A gynecologic oncology group study , 1993, Cancer.

[2]  J. Niloff,et al.  Use of peripheral-blood progenitor cells abrogates the myelotoxicity of repetitive outpatient high-dose carboplatin and cyclophosphamide chemotherapy. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  I. Christensen,et al.  A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. , 1983, Cytometry.

[4]  C. Dunton,et al.  Low-grade stromal sarcoma: DNA flow cytometric analysis and estrogen progesterone receptor data. , 1990, Gynecologic oncology.

[5]  I W Taylor,et al.  Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. , 1983, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[6]  H. Evans.  Endometrial stromal sarcoma and poorly differentiated endometrial sarcoma , 1982, Cancer.

[7]  C. Zaloudek,et al.  Mesenchymal Tumors of the Uterus , 1987 .

[8]  K. Bauer,et al.  Neoplasms of endometrial stroma: histopathologic and flow cytometric analysis with clinical correlation. , 1989, Human pathology.

[9]  A. Landay,et al.  Advances in flow cytometry for diagnostic pathology. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[10]  F. Pettersson,et al.  Prognostic factors in uterine leiomyosarcoma. A clinical and histopathological study of 143 cases. The Radiumhemmet series 1936-1981. , 1990, Acta oncologica.

[11]  F. Abdul-Karim,et al.  Uterine stromal neoplasms: a clinicopathologic and DNA flow cytometric correlation. , 1991, Human pathology.

[12]  K. Chang,et al.  Primary Uterine Endometrial Stromal Neoplasms: A Clinicopathologic Study of 117 Cases , 1990, The American journal of surgical pathology.

[13]  K. Tsushima,et al.  Uterine leiomyosarcomas and benign smooth muscle tumors: usefulness of nuclear DNA patterns studied by flow cytometry. , 1988, Mayo Clinic proceedings.

[14]  W. Hiddemann,et al.  Convention on nomenclature for DNA cytometry , 1984 .

[15]  M. Petrovecki,et al.  Tumor cell cycle in patients with stage I endometrial carcinoma. , 1994, Gynecologic oncology.

[16]  P. V. van Dam,et al.  Flow cytometric DNA analysis in gynecological oncology , 1991, International Journal of Gynecologic Cancer.

[17]  L. Koss,et al.  Flow cytometric DNA analysis of human solid tumors: a review of the interpretation of DNA histograms. , 1991, Human pathology.

[18]  F. Pettersson,et al.  Endometrial stromal sarcoma of the uterus. A clinical and histopathological study. The Radiumhemmet series 1936-1981. , 1990, European journal of obstetrics, gynecology, and reproductive biology.

[19]  W. Andersen,et al.  Deoxyribonucleic acid analysis by flow cytometry of uterine leiomyosarcomas and smooth muscle tumors of uncertain malignant potential. , 1992, American journal of obstetrics and gynecology.

[20]  W. McGuire,et al.  Ploidy, proliferative activity and prognosis. DNA flow cytometry of solid tumors , 1990, Cancer.

[21]  M. Wells,et al.  Mixed Mullerian tumors of the uterine corpus: a review , 1992, International Journal of Gynecologic Cancer.

[22]  C. Tropé,et al.  Leiomyosarcoma (LMS) and endometrial stromal sarcoma (ESS) of the uterus. A survey of patients treated in the Norwegian Radium Hospital 1976–1985 , 1992, International Journal of Gynecologic Cancer.

[23]  D. Jukic,et al.  Prognostic value of steroid hormone receptors concentration in patients with endometrial Carcinoma , 1994, Acta obstetricia et gynecologica Scandinavica.

[24]  R. Kempson,et al.  Problematic Uterine Smooth Muscle Neoplasms: A Clinicopathologic Study of 213 Cases , 1994, The American journal of surgical pathology.